Avantax Advisory Services’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.55M Sell
23,553
-13,240
-36% -$5.37M 0.05% 280
2025
Q1
$18.3M Sell
36,793
-621
-2% -$309K 0.11% 140
2024
Q4
$19.5M Buy
37,414
+325
+0.9% +$169K 0.12% 128
2024
Q3
$22.9M Sell
37,089
-373
-1% -$231K 0.15% 103
2024
Q2
$20.7M Buy
37,462
+14,723
+65% +$8.14M 0.15% 107
2024
Q1
$13.2M Buy
22,739
+331
+1% +$192K 0.12% 133
2023
Q4
$11.9M Buy
22,408
+2,310
+11% +$1.23M 0.12% 138
2023
Q3
$10.2M Buy
20,098
+234
+1% +$118K 0.11% 140
2023
Q2
$10.4M Buy
19,864
+356
+2% +$186K 0.12% 141
2023
Q1
$11.2M Buy
19,508
+889
+5% +$512K 0.14% 123
2022
Q4
$10.3M Buy
18,619
+1,347
+8% +$742K 0.14% 127
2022
Q3
$8.76M Buy
17,272
+934
+6% +$474K 0.13% 120
2022
Q2
$8.88M Buy
16,338
+4,834
+42% +$2.63M 0.13% 126
2022
Q1
$6.81M Buy
11,504
+903
+9% +$535K 0.09% 155
2021
Q4
$7.08M Buy
10,601
+1,070
+11% +$715K 0.11% 147
2021
Q3
$5.45M Buy
9,531
+1,902
+25% +$1.09M 0.09% 167
2021
Q2
$3.89M Buy
7,629
+1,015
+15% +$517K 0.07% 206
2021
Q1
$3.02M Buy
6,614
+750
+13% +$343K 0.06% 224
2020
Q4
$2.74M Sell
5,864
-3,128
-35% -$1.46M 0.07% 210
2020
Q3
$3.98M Buy
8,992
+4,689
+109% +$2.07M 0.06% 236
2020
Q2
$1.56M Buy
4,303
+1,718
+66% +$622K 0.04% 266
2020
Q1
$734K Sell
2,585
-2,250
-47% -$639K 0.02% 353
2019
Q4
$1.57M Buy
4,835
+158
+3% +$51.4K 0.04% 254
2019
Q3
$1.36M Buy
4,677
+139
+3% +$40.5K 0.06% 171
2019
Q2
$1.33M Buy
4,538
+450
+11% +$132K 0.06% 160
2019
Q1
$1.12M Buy
4,088
+2,880
+238% +$788K 0.06% 160
2018
Q4
$272K Buy
+1,208
New +$272K 0.05% 314